Evaluation of utility and safety of new laxative (Moviprep) for preparation of colonoscopy in patients with inflammatory bowel diseases
Not Applicable
- Conditions
- inflammatory bowel diseases
- Registration Number
- JPRN-UMIN000010609
- Lead Sponsor
- Saitama Medical Center, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who has obstruction and/or suspicious obstruction of gastorointestinal tract Patients who has perforation and/or suspicious perforation ofgastorointestinal tract Patients who has delayed exhaust in stomach Patients with toxic megacolon Patients who has allergy of laxatives Patinets who are determiend not to be appropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clensing effects of laxatives
- Secondary Outcome Measures
Name Time Method Persentage of patients who underwent colonoscopy Dose and time of laxatives for the preparation of colonoscopy Changes of body weight Blood chemistry and urine examination Clinical activity after colonoscopy Capability of using laxatives Adverse enents